HK2 and posterior cortical atrophy: Combination treatment with the glucose analogue 2-deoxy-D-glucose (2-DG), which inhibits HK2 activity, could resensitize PCa cells to enzalutamide, suggesting that it would be helpful to provide an additional therapeutic approach by characterizing the role of HK2 in PCa.